{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:31:56Z","timestamp":1792204316511,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10930-025-10251-2","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T18:58:08Z","timestamp":1739127488000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia Cells"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-6603","authenticated-orcid":false,"given":"Hamza","family":"Halici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-282X","authenticated-orcid":false,"given":"Harun","family":"Un","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-2471","authenticated-orcid":false,"given":"Saffet","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4281-0103","authenticated-orcid":false,"given":"Zeynep","family":"Karakoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-5943","authenticated-orcid":false,"given":"Zafer","family":"Bayraktutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-1177","authenticated-orcid":false,"given":"Can","family":"Ozlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-7205","authenticated-orcid":false,"given":"Elif","family":"Cadirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-6059","authenticated-orcid":false,"given":"Zekai","family":"Halici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7027-809X","authenticated-orcid":false,"given":"Alptug","family":"Atila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-1534","authenticated-orcid":false,"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,9]]},"reference":[{"key":"10251_CR1","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3390\/molecules24162997","volume":"24","author":"R Wehbe","year":"2019","unstructured":"Wehbe R, Frangieh J, Rima M et al (2019) Bee Venom: overview of Main compounds and bioactivities for therapeutic interests. Molecules 24:2997. https:\/\/doi.org\/10.3390\/molecules24162997","journal-title":"Molecules"},{"key":"10251_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10555-011-9339-3","volume":"31","author":"N Or\u0161oli\u0107","year":"2012","unstructured":"Or\u0161oli\u0107 N (2012) Bee venom in cancer therapy. Cancer Metastasis Rev 31:173\u2013194. https:\/\/doi.org\/10.1007\/s10555-011-9339-3","journal-title":"Cancer Metastasis Rev"},{"key":"10251_CR3","doi-asserted-by":"publisher","unstructured":"Pucca MB, Cerni FA, Oliveira IS et al (2019) Bee updated: current knowledge on Bee Venom and Bee Envenoming Therapy. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02090","DOI":"10.3389\/fimmu.2019.02090"},{"key":"10251_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10540-006-9030-z","volume":"27","author":"H Raghuraman","year":"2007","unstructured":"Raghuraman H, Chattopadhyay A (2007) Melittin: a membrane-active peptide with diverse functions. Biosci Rep 27:189\u2013223. https:\/\/doi.org\/10.1007\/s10540-006-9030-z","journal-title":"Biosci Rep"},{"key":"10251_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/ijd.12161","volume":"52","author":"JS Park","year":"2013","unstructured":"Park JS, Lee MJ, Chung KH et al (2013) Live bee acupuncture (Bong-Chim) dermatitis: Dermatitis due to live bee acupuncture therapy in Korea. Int J Dermatol 52:1519\u20131524. https:\/\/doi.org\/10.1111\/ijd.12161","journal-title":"Int J Dermatol"},{"key":"10251_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.toxicon.2018.09.013","volume":"154","author":"EP Cherniack","year":"2018","unstructured":"Cherniack EP, Govorushko S (2018) To bee or not to bee: the potential efficacy and safety of bee venom acupuncture in humans. Toxicon 154:74\u201378. https:\/\/doi.org\/10.1016\/j.toxicon.2018.09.013","journal-title":"Toxicon"},{"key":"10251_CR7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/toxins7041126","volume":"7","author":"M Moreno","year":"2015","unstructured":"Moreno M, Giralt E (2015) Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: Melittin, apamin and mastoparan. Toxins (Basel) 7:1126\u20131150. https:\/\/doi.org\/10.3390\/toxins7041126","journal-title":"Toxins (Basel)"},{"key":"10251_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/toxins7030846","volume":"7","author":"MD Cai","year":"2015","unstructured":"Cai MD, Choi SM, Yang EJ (2015) The effects of bee venom acupuncture on the central nervous system and muscle in an animal hsOD1G93A mutant. Toxins (Basel) 7:846\u2013858. https:\/\/doi.org\/10.3390\/toxins7030846","journal-title":"Toxins (Basel)"},{"key":"10251_CR9","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/toxins7072413","volume":"7","author":"DS Hwang","year":"2015","unstructured":"Hwang DS, Kim SK, Bae H (2015) Therapeutic effects of bee venom on immunological and neurological diseases. Toxins (Basel) 7:2413\u20132421. https:\/\/doi.org\/10.3390\/toxins7072413","journal-title":"Toxins (Basel)"},{"key":"10251_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ctim.2013.02.001","volume":"21","author":"SY Cho","year":"2013","unstructured":"Cho SY, Park JY, Jung WS et al (2013) Bee venom acupuncture point injection for central post stroke pain: a preliminary single-blind randomized controlled trial. Complement Ther Med 21:155\u2013157. https:\/\/doi.org\/10.1016\/j.ctim.2013.02.001","journal-title":"Complement Ther Med"},{"key":"10251_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.21037\/jgo-22-222","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Hu W, Zhang Z et al (2022) Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration. J Gastrointest Oncol 13:847\u2013858. https:\/\/doi.org\/10.21037\/jgo-22-222","journal-title":"J Gastrointest Oncol"},{"key":"10251_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8916464","volume":"2022","author":"JE Yu","year":"2022","unstructured":"Yu JE, Kim Y, Hong DE et al (2022) Bee Venom triggers Autophagy-Induced apoptosis in Human Lung Cancer cells via the mTOR Signaling Pathway. J Oncol 2022:1\u201313. https:\/\/doi.org\/10.1155\/2022\/8916464","journal-title":"J Oncol"},{"key":"10251_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.taap.2011.10.009","volume":"258","author":"M Jo","year":"2012","unstructured":"Jo M, Park MH, Kollipara PS et al (2012) Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2\/STAT3 pathway. Toxicol Appl Pharmacol 258:72\u201381. https:\/\/doi.org\/10.1016\/j.taap.2011.10.009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10251_CR14","first-page":"237","volume":"22","author":"SW Ip","year":"2008","unstructured":"Ip SW, Liao SS, Lin SY et al (2008) The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells. Vivo (Brooklyn) 22:237\u2013246","journal-title":"Vivo (Brooklyn)"},{"key":"10251_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1442-2042.2011.02876.x","volume":"19","author":"SW Ip","year":"2012","unstructured":"Ip SW, Chu YL, Yu CS et al (2012) Bee venom induces apoptosis through intracellular ca 2+-modulated intrinsic death pathway in human bladder cancer cells. Int J Urol 19:61\u201370. https:\/\/doi.org\/10.1111\/j.1442-2042.2011.02876.x","journal-title":"Int J Urol"},{"key":"10251_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2009.11.013","volume":"292","author":"JE Huh","year":"2010","unstructured":"Huh JE, Baek YH, Lee MH et al (2010) Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice. Cancer Lett 292:98\u2013110. https:\/\/doi.org\/10.1016\/j.canlet.2009.11.013","journal-title":"Cancer Lett"},{"key":"10251_CR17","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/hep.22240","volume":"47","author":"S Liu","year":"2008","unstructured":"Liu S, Yu M, He Y et al (2008) Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 47:1964\u20131973. https:\/\/doi.org\/10.1002\/hep.22240","journal-title":"Hepatology"},{"key":"10251_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pros.21296","volume":"71","author":"MH Park","year":"2011","unstructured":"Park MH, Choi MS, Kwak DH et al (2011) Anti-cancer effect of bee venomin prostate cancer cells through activation of caspase pathway via inactivation of NF-\u03baB. Prostate 71:801\u2013812. https:\/\/doi.org\/10.1002\/pros.21296","journal-title":"Prostate"},{"key":"10251_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/biom10020247","volume":"10","author":"M Ceremuga","year":"2020","unstructured":"Ceremuga M, Stela M, Janik E et al (2020) Melittin\u2014A natural peptide from Bee Venom which induces apoptosis in human leukaemia cells. Biomolecules 10:247. https:\/\/doi.org\/10.3390\/biom10020247","journal-title":"Biomolecules"},{"key":"10251_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/toxins16030117","volume":"16","author":"G Gajski","year":"2024","unstructured":"Gajski G, Leonova E, Sjakste N (2024) Bee Venom: composition and Anticancer properties. Toxins (Basel) 16:117. https:\/\/doi.org\/10.3390\/toxins16030117","journal-title":"Toxins (Basel)"},{"key":"10251_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.31557\/APJCP.2020.21.5.1487","volume":"21","author":"SM Namayandeh","year":"2020","unstructured":"Namayandeh SM, Khazaei Z, Lari Najafi M et al (2020) GLOBAL leukemia in children 0\u201314 statistics 2018, incidence and mortality and Human Development Index (HDI): GLOBOCAN sources and methods. Asian Pac J Cancer Prev 21:1487\u20131494. https:\/\/doi.org\/10.31557\/APJCP.2020.21.5.1487","journal-title":"Asian Pac J Cancer Prev"},{"key":"10251_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0005-2736(97)00236-8","volume":"1369","author":"G Carrasquer","year":"1998","unstructured":"Carrasquer G, Li M, Yang S, Schwartz M (1998) Effect of melittin on PD, resistance and short-circuit current in the frog gastric mucosa. Biochim Biophys Acta - Biomembr 1369:346\u2013354. https:\/\/doi.org\/10.1016\/S0005-2736(97)00236-8","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10251_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0090-6980(02)00020-5","volume":"68\u201369","author":"I Kudo","year":"2002","unstructured":"Kudo I, Murakami M (2002) Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68\u201369:3\u201358. https:\/\/doi.org\/10.1016\/s0090-6980(02)00020-5","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10251_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S1388-1981(02)00152-X","volume":"1582","author":"MH Gr\u00e4ler","year":"2002","unstructured":"Gr\u00e4ler MH, Goetzl EJ (2002) Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta - Mol Cell Biol Lipids 1582:168\u2013174. https:\/\/doi.org\/10.1016\/S1388-1981(02)00152-X","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"10251_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0360-3016(00)01476-0","volume":"49","author":"GA Ruiter","year":"2001","unstructured":"Ruiter GA, Verheij M, Zerp SF, Van Blitterswijk WJ (2001) Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys 49:415\u2013419. https:\/\/doi.org\/10.1016\/S0360-3016(00)01476-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10251_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5152\/eurasianjmed.2020.20033","volume":"52","author":"I Cinar","year":"2020","unstructured":"Cinar I, Yayla M, Celik M et al (2020) Role of endothelin 1 on proliferation and migration of human MCF-7 cells. Eurasian J Med 52:277\u2013282. https:\/\/doi.org\/10.5152\/eurasianjmed.2020.20033","journal-title":"Eurasian J Med"},{"key":"10251_CR27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.17826\/cumj.732912","volume":"45","author":"I Cinar","year":"2020","unstructured":"Cinar I, Yayla M, Binnetoglu D (2020) Gossypinin insan hepatom (Hep-3B) h\u00fccreleri \u00fczerinde anti-proliferatif etkisi. Cukurova Med J 45:1165\u20131172. https:\/\/doi.org\/10.17826\/cumj.732912","journal-title":"Cukurova Med J"},{"key":"10251_CR28","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1021\/acs.jproteome.8b00175","volume":"17","author":"H Barsnes","year":"2018","unstructured":"Barsnes H, Vaudel M (2018) SearchGUI: a highly adaptable common interface for Proteomics Search and De Novo engines. J Proteome Res 17:2552\u20132555. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00175","journal-title":"J Proteome Res"},{"key":"10251_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/pr400307u.Immunodepletion","volume":"12","author":"KA Jones","year":"2013","unstructured":"Jones KA, Kim PD, Patel BB et al (2013) Immunodepletion plasma proteomics by TripleTOF 5600 and Orbitrap Elite\/LTQ-Orbitrap Velos\/Q Exactive Mass Spectrometers. J Proteome Res 12:1\u201327. https:\/\/doi.org\/10.1021\/pr400307u.Immunodepletion","journal-title":"J Proteome Res"},{"key":"10251_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2016-03-643544.The","volume":"2","author":"A Arber","year":"2016","unstructured":"Arber A, Orazi D A (2016) The updated WHO classification of hematological malignancies: the 2016 revision to the WHO classification of myeloid neoplasms and acute leukemia. Blood J 2:58\u201371. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.The","journal-title":"Blood J"},{"key":"10251_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules23030692","volume":"23","author":"MA Moga","year":"2018","unstructured":"Moga MA, Dimienescu OG, Arv\u01cetescu CA et al (2018) Anticancer activity of toxins from bee and snake venom-an overview on ovarian cancer. Molecules 23:1\u201321. https:\/\/doi.org\/10.3390\/molecules23030692","journal-title":"Molecules"},{"key":"10251_CR32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1211\/002235702320266235","volume":"54","author":"X Liu","year":"2010","unstructured":"Liu X, Chen D, Xie L, Zhang R (2010) Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo. J Pharm Pharmacol 54:1083\u20131089. https:\/\/doi.org\/10.1211\/002235702320266235","journal-title":"J Pharm Pharmacol"},{"key":"10251_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.toxicon.2004.09.017","volume":"45","author":"CS Yin","year":"2005","unstructured":"Yin CS, Lee HJ, Hong SJ et al (2005) Microarray analysis of gene expression in chondrosarcoma cells treated with bee venom. Toxicon 45:81\u201391. https:\/\/doi.org\/10.1016\/j.toxicon.2004.09.017","journal-title":"Toxicon"},{"key":"10251_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1211\/jpp.58.1.0010","volume":"58","author":"H Hu","year":"2010","unstructured":"Hu H, Chen D, Li Y, Zhang X (2010) Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb\/c nude mice in-vivo. J Pharm Pharmacol 58:83\u201389. https:\/\/doi.org\/10.1211\/jpp.58.1.0010","journal-title":"J Pharm Pharmacol"},{"key":"10251_CR35","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.intimp.2006.07.027","volume":"6","author":"DO Moon","year":"2006","unstructured":"Moon DO, Park SY, Heo MS et al (2006) Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. Int Immunopharmacol 6:1796\u20131807. https:\/\/doi.org\/10.1016\/j.intimp.2006.07.027","journal-title":"Int Immunopharmacol"},{"key":"10251_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0041-0101(03)00045-X","volume":"41","author":"N Or\u0161oli\u0107","year":"2003","unstructured":"Or\u0161oli\u0107 N, \u0160ver L, Verstov\u0161ek S et al (2003) Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon 41:861\u2013870. https:\/\/doi.org\/10.1016\/S0041-0101(03)00045-X","journal-title":"Toxicon"},{"key":"10251_CR37","first-page":"553","volume":"54","author":"K \u015aladowska","year":"2016","unstructured":"\u015aladowska K, Handzlik J, Kie\u0107-Kononowicz K, Mazur L (2016) In vitro cytotoxic activity evaluation of phenytoin derivatives against human leukemia cells. Indian J Exp Biol 54:553\u2013559","journal-title":"Indian J Exp Biol"},{"key":"10251_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cdd.2014.137","volume":"22","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Bravo-San Pedro JM, Vitale I et al (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 22:58\u201373. https:\/\/doi.org\/10.1038\/cdd.2014.137","journal-title":"Cell Death Differ"},{"key":"10251_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.toxicon.2007.08.015","volume":"51","author":"DO Moon","year":"2008","unstructured":"Moon DO, Park SY, Choi YH et al (2008) Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of akt phosphorylation in human leukemic U937 cells. Toxicon 51:112\u2013120. https:\/\/doi.org\/10.1016\/j.toxicon.2007.08.015","journal-title":"Toxicon"},{"key":"10251_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10989-017-9641-1","volume":"24","author":"H Zarrinnahad","year":"2018","unstructured":"Zarrinnahad H, Mahmoodzadeh A, Hamidi MP et al (2018) Apoptotic effect of Melittin purified from Iranian Honey Bee Venom on human cervical Cancer HeLa cell line. Int J Pept Res Ther 24:563\u2013570. https:\/\/doi.org\/10.1007\/s10989-017-9641-1","journal-title":"Int J Pept Res Ther"},{"key":"10251_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/jpp\/rgad008","volume":"75","author":"Y Luo","year":"2023","unstructured":"Luo Y, Xu C, Luo B et al (2023) Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis. J Pharm Pharmacol 75:645\u2013654. https:\/\/doi.org\/10.1093\/jpp\/rgad008","journal-title":"J Pharm Pharmacol"},{"key":"10251_CR42","doi-asserted-by":"publisher","unstructured":"Sevin S, Deveci Ozkan A, Tutun H et al (2023) Determination of the effects of Bee Venom on Triple negative breast Cancer cells in Vitro. Chem Biodivers 20. https:\/\/doi.org\/10.1002\/cbdv.202201263","DOI":"10.1002\/cbdv.202201263"},{"key":"10251_CR43","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00262-006-0143-9","volume":"55","author":"T Putz","year":"2006","unstructured":"Putz T, Ramoner R, Gander H et al (2006) Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate. Cancer Immunol Immunother 55:1374\u20131383. https:\/\/doi.org\/10.1007\/s00262-006-0143-9","journal-title":"Cancer Immunol Immunother"},{"key":"10251_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40409-015-0042-7","volume":"21","author":"KCF Bordon","year":"2015","unstructured":"Bordon KCF, Wiezel GA, Amorim FG, Arantes EC (2015) Arthropod venom hyaluronidases: biochemical properties and potential applications in medicine and biotechnology. J Venom Anim Toxins Incl Trop Dis 21:43. https:\/\/doi.org\/10.1186\/s40409-015-0042-7","journal-title":"J Venom Anim Toxins Incl Trop Dis"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-025-10251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-025-10251-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-025-10251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:15:56Z","timestamp":1750943756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-025-10251-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10251"],"URL":"https:\/\/doi.org\/10.1007\/s10930-025-10251-2","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"value":"1572-3887","type":"print"},{"value":"1875-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,9]]},"assertion":[{"value":"31 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}